MATTHEW T. SCHELP. St. Louis, MO office:

Similar documents
PATRICK S. COFFEY. Chicago, IL office: office:

GEORGE B. NEWHOUSE, JR., Senior Attorney

1/29/2011. Mark G. Bodner Bureau Chief Complex Civil Enforcement Bureau Medicaid Control Unit Office of the Attorney General

Eric B. Bruce Lawyer WASHINGTON DC NEW YORK. Admissions

Eric H. Cottrell Partner

Eric B. Bruce Lawyer WASHINGTON DC NEW YORK. Admissions

Ross O. Silverman. Partner Chicago p Practices. Industries. Recognition. Selected Experience.

Self-Disclosure: Why, When, Where and How

David J. Leviss Partner

Daly D.E. Temchine Counsel

White Collar. Criminal Defense & Internal Investigations Practice. Practical Wisdom, Trusted Advice.

From the Office Suite to Cell Block C: Potential Criminal and Regulatory Implications of Pharma/Biotech/Device Products Liability Lawsuits

Litigation & Dispute Resolution

R E P R I N T JAN-MAR Inside this issue: The evolving role of the chief risk officer Managing your company s regulatory exposure

2017 Year-End Review: Anti-Corruption Trends and Other Corporate Enforcement Issues

Matthew D. Lee Partner

The False Claims Act and Financial Institutions: A New Role for an Old Statute

Lynn A. Neils PARTNER EDUCATION AND HONORS

Anti-Kickback Statute and False Claims Act Enforcement

U.S. v. Sulzbach: Government Theories, Potential Defenses, and Lessons Learned

A DISCUSSION WITH THE OIG

Regulatory Compliance Policy No. COMP-RCC 4.21 Title:

M. Gabrielle Hils Of Counsel

Dennis E. Boyle. Senior Counsel. Experience

Whistleblowing Under the False Claims Act

It s Here: The Final 60 Day Overpayment Rule

Corporate Integrity Agreements can be the basis for a False Claims Act Case

WHITE COLLAR, SECURITIES ENFORCEMENT, AND GOVERNMENT INVESTIGATIONS

STATEMENT OF MICHAEL F. HERTZ DEPUTY ASSISTANT ATTORNEY GENERAL CIVIL DIVISION UNITED STATES DEPARTMENT OF JUSTICE BEFORE THE

Corporate Compliance Program. Intended Audience: All SEH Associates 2016 Content Expert: Lisa Frey -

Preparing for the new age of global anti-corruption enforcement Presentation to WPACC. October 15, 2013

Office of Inspector General. Regional Enforcement Efforts and Priorities in Florida. South Atlantic Regional Conference January 28, 2011

Beazley Remedy New Business Regulatory Liability Application

State False Claims Acts

418, which is frequently referred to as the Prompt Pay Legislation (SB 418). SB 418

ARE PHYSICIAN MSOs LEGAL?

The Salcido Report. False Claims Act Public Disclosure Alert. If you read one thing...

Kauffman Kilberg LLC. The Congress Center 1001 SW Fifth Avenue Suite 1414 Portland, OR 97204

The False Claims Act. False Claims Act Basics (I)

GERALD (JERRY) LEWANDOWSKI. BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, Second Floor Washington, DC 20036

Industry Funding of Continuing Medical Education

Federal and State Litigation Regarding Pharmacy Benefit Managers

MEMORANDUM OF UNDERSTANDING

Clinical and Administrative Policies and Procedures

What To Do When The Feds Come Knocking. Christine Williams Dave Taylor

Health Care Practice Center

Charging, Coding and Billing Compliance

The Road Ahead. Diane Meyer Chief Compliance and Privacy Officer Stanford University Medical Center

Kauffman Kilberg LLC. The Congress Center 1001 SW Fifth Avenue Suite 1414 Portland, OR 97204

Benson E. Pope. Focus Areas. Overview

REETUPARNA (REENA) DUTTA Partner

Gregory Keating. Practice Group Leader PRACTICE FOCUS. EDUCATION Boston College Law School JD, 1993, cum laude. Trinity College BA, 1987

This course is designed to provide Part B providers with an overview of the Medicare Fraud and Abuse program including:

False Claims Act Enforcement in the Managed Care Space: Recent Trends and Proactive Compliance Tips

DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All NEW YORK WORKFORCE MEMBERS

Conflicts of Interest 9/10/2017. Everything a Health Care Executive Needs to Know about the Anti-Kickback Statute. May 2, 2017 Article from JAMA:

LITIGATING AWP. Mitch Lazris/Lyndon Tretter Hogan & Hartson L.L.P. November 15, 2002

Stark Self-Disclosure. Thomas S. Crane 1/ Mintz Levin Cohn Ferris Glovsky and Popeo, PC

Benson E. Pope. Focus Areas. Overview

PHYSICIAN INVESTMENT COMPLIANCE

Deciphering the Self-Disclosure Puzzle

Contents of Presentation:

Peter C. Anderson. Principal I Street, N.W., Suite 700, Washington, DC,

FINANCIAL DISCLOSURES AND CONFLICTS OF INTEREST IN CLINICAL RESEARCH

Establishing an Anti-Corruption Compliance Program in Canada

The False Claims Act and Off-Label Promotion: Understanding and Minimizing the Risks for Pharmaceutical Manufacturers

FRAUD, WASTE, & ABUSE (FWA) for Brokers. revised 10/17

AHLA. A. False Claims Act Primer. Thomas A. Corcoran Assistant US Attorney US Attorney s Office District of Maryland Baltimore, MD

Doing Business in the World of Whistleblowers. A Discussion of Enforcement Trends, Emerging Prosecution Tactics and Practical Compliance Strategies

The Anesthesia Company Model: Frequently Asked Questions

SUNY DOWNSTATE MEDICAL CENTER POLICY AND PROCEDURE. No:

Record False Claims Act Settlement Against For-Profit Education Company

Kymberly Kochis. P: E:

David C. Gair. Partner

How to Conduct an Internal Investigation

D. Brian Hufford. Partner

Medicaid Report: New Hampshire. Exploring Measures to Prevent and Detect Fraud

Corporate Compliance Topic: False Claims Act and Whistleblower Provisions

HEATHER I. BATES Managing Director, BRG Health Analytics. BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, 2 nd Floor Washington, DC 20036

D E B R A S C H U C H E R T, C O M P L I A N C E O F F I C E R

FAST BREAK: GOVERNMENT ENFORCEMENT OF INDIVIDUAL ACCOUNTABILITY. Katie McDermott Jacob Harper February 28, Morgan, Lewis & Bockius LLP

Potential Perils of Using New Media in Marketing and Promotion. Christina M. Markus (202)

FALSE CLAIMS ACT ENFORCEMENT: RECENT TRENDS AND STEPS TO ENSURE COMPLIANCE AND AVOID FRAUD ALLEGATIONS

11/10/2014. Nuts and Bolts of Proceedings related to Fraud, Recent Cases Update, and HIPAA Nuances. Objectives

DEPARTMENT OF HEALTH AND HUMAN SERVICES. Office of Inspector General s Use of Agreements to Protect the Integrity of Federal Health Care Programs

Darren E. Nadel. Focus Areas. Overview

POTENTIAL FRAUD ISSUES IN THE OPERATION OF PHARMACY BENEFIT MANAGEMENT ENTITIES

Federal Fraud and Abuse Enforcement in the ASC Space

Fraud and Abuse Compliance for the Health IT Industry

Section (Primary Department) Medicaid Special Investigations Unit. Effective Date Date of Last Review 01/30/2015 Department Approval/Signature :

Eric C. Rowe. Counsel. Experience M Street, NW Suite 450N Washington, DC Phone: Fax:

Building a Strategic Plan for Physician Employment and Practice Acquisition

Securities, Financial and Directors & Officers Litigation. Practice Overview

PBM REGULATION,INVESTIGATION,PROSE CUTION,AND COMPLIANCE PHARMA AUDIOCONFERENCE FEBRUARY 10, 2004

Defending Whistleblower Cases: An Advanced View From the Trenches. Gregory M. Luce Jones Day

SEC Adopts Final Rules on the Dodd-Frank Whistleblower Program But Is This a Game Changer?

Improving Integrity in Nursing Centers

TRENDS IN HEALTH CARE FRAUD Mark E. Donnelly Deputy Chief- Criminal Division

TRENDS IN HEALTH CARE FRAUD Mark E. Donnelly Deputy Chief- Criminal Division

Financial Services Update September 23, 2015

Transcription:

MATTHEW T. SCHELP Partner St. Louis, MO office: 314.480.1772 email: matthew.schelp@ Overview A former federal prosecutor, Matt concentrates his practice in the areas of compliance, internal investigations, tax, whistleblower defense, white collar defense, Foreign Corrupt Practices Act (FCPA), securities enforcement and business litigation. He leads the firm s Government Compliance, Investigations & Litigation practice group. Matt regularly leads internal investigations on behalf of clients throughout the United States and internationally. In that representation, Matt interacts with the Department of Justice (DOJ), Securities and Exchange Commission (SEC), Environmental Protection Agency (EPA) and other state and federal criminal enforcement and regulatory authorities. He frequently represents public and private entities, senior corporate executives, employees and other individuals in matters involving environmental violations and regulatory compliance, False Claims Act/qui tam litigation, financial institution fraud, government procurement fraud, healthcare fraud, insider trading, insurance fraud, securities fraud, tax controversies, tax fraud and evasion and alleged violations of the FCPA. Industries Healthcare Manufacturing Technology Transportation Services Employment Claims Defense Evasion & Circumvention Government Compliance, Investigations & Litigation Government Solutions Healthcare Regulatory & Compliance Counseling Tax Tax Controversy White Collar Defense For nearly a decade, Matt served as an assistant U.S. attorney in the capacity of a white collar prosecutor and deputy healthcare fraud

coordinator. In this role, he was responsible for the evaluation, investigation and prosecution of fraud and criminal healthcare matters in the U.S. District Court, Eastern District of Missouri. Matt founded Jensen Bartlett & Schelp in 2009 and was senior advisor with the Ashcroft Law Firm before joining Husch Blackwell. He previously served three years active duty and 11 years as a reservist in the U.S. Navy Judge Advocate General s Corps. Obtained one of the first ever permanent injunctions under the Defense of Trade Secret Acts in a high profile corporate espionage and deceptive trade secrets case. Monsanto Company et al v. Chen No. 4:16-cv-00876-CDP, United States District Court Eastern District of Missouri. Obtained motion to dismiss in the representation of a healthcare facility in a qui tam matter before the United States District Court, District of Colorado. Successfully obtained the closure of a joint DOJ/SEC investigation of a publically traded national real estate/mall developer. Resolved criminal charges against a doctor and his practice. Handled all phases of the investigation, including the criminal and civil litigation, and favorably resolved Centers for Medicare & Medicaid Services (CMS) exclusion litigation. Represented a variety of individuals and entities in insider trading enforcement actions brought by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC). Conducted numerous internal investigations for publicly-traded and privately held companies in a variety of industries, including sustainable agriculture, healthcare, manufacturing, defense contracting and religious organizations. Internal investigations in the areas of healthcare fraud, employee misconduct, data breaches and environmental violations. Represented individuals and publicly traded entities against allegations by the SEC and DOJ of FCPA violations. Successfully resolved tax controversy issues (civil fraud penalty), thus saving the client more than $2 million. Represented home healthcare provider in criminal investigation by the Missouri Attorney General s Medicaid Fraud Control Unit (MFCU) regarding allegations of fraudulent billing. Successfully represented employees of a Major League Baseball team in a data breach, corporate espionage matter.

Favorably resolved Clean Water Act violation and DOJ environmental criminal investigation and prosecution. Represented adult day-care provider in MFCU investigation. Represented pharmacist and pharmacy corporation in federal criminal prosecution and related resolution of civil False Claims Act lawsuit. Represented a durable medical equipment provider in federal whistleblower matter alleging fraudulent billing practices. Represented a variety of individuals and entities in investigations involving Drug Enforcement Administration (DEA) diversion. Represented physicians before the Missouri Board of Healing Arts. Defended pharmaceutical manufacturer in a criminal Food and Drug Administration (FDA) investigation regarding quality controls, validation of manufacturing protocols and timeliness and accuracy of field alert submissions. Participated in the review, implementation and creation of a comprehensive compliance program for a major U.S.-based medical device manufacturer. This engagement involved: Conducted a thorough analysis of the compliance performance and systems. Assessing the early detection system and risk assessment tools. Utilized a risk-reduction strategy to achieve industry-leading, sustainable and profitable compliance practices. Audited systems and controls for compliance-related vulnerabilities. Assessed the effectiveness of the compliance training program. Monitoring initial changes resulting from recommendations and remediation. Assisted the company in addressing necessary cultural changes within the organization. Developed an internal investigative protocol and developing employee whistleblower best practices. Reduced the risk of compliance-related enforcement actions and investigations.

Obtained appellate decision affirming trial court's defense verdict in whistleblower case. Plaintiff had alleged that healthcare provider's hospital referrals violated anti-kickback statute, False Claims Act and Colorado state law. Recognition Missouri & Kansas Super Lawyers, Criminal Defense: White Collar, 2018 Missouri Lawyers Weekly, Up and Coming Lawyer, 2007 Education J.D., University of Missouri School of Law B.S.B.A., University of Missouri Columbia School of Business

Admissions U.S. Court of Appeals, Armed Forces U.S. District Court, District of Colorado Missouri U.S. District Court, District of Kansas Kansas Colorado U.S. District Court, Eastern District of Missouri U.S. District Court, Eastern District of Tennessee U.S. District Court, Northern District of Florida U.S. District Court, Western District of Missouri U.S. District Court, Western District of Texas U.S. Tax Court U.S. Court of Appeals, Tenth Circuit U.S. Court of Appeals, Eighth Circuit Missouri Supreme Court